These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2913730)

  • 1. Clinical and hemodynamic effects of long-term administration of gallopamil in patients with coronary artery disease and normal or impaired left ventricular function.
    Tartagni F; Maiello L; Marchetti G; Dondi M; Franchi R; Monetti N; Magnani B
    Am J Cardiol; 1989 Feb; 63(5):291-5. PubMed ID: 2913730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
    Mitrovic V; Oehm E; Thormann J; Pitschner H; Haberbosch W
    Clin Cardiol; 1998 Jul; 21(7):492-502. PubMed ID: 9669058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise cardiovascular responses to gallopamil in ischemic heart disease.
    Terrosu P; Ibba GV; Pes R; Contini GM; Delpini A; Franceschino V; Fantoccoli D; Magri M
    Int J Cardiol; 1991 Oct; 33(1):75-81. PubMed ID: 1937985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gallopamil on myocardial microperfusion in patients with stable effort angina: a randomized, cross-over, double-blind, placebo-controlled trial.
    Acanfora D; Vitale DF; Rengo C; Iannuzzi GL; Furgi G; Picone C; Rossi M; Trojano L; Rengo F
    Cardiology; 1997; 88(4):353-60. PubMed ID: 9197430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise-induced symptomatic and asymptomatic myocardial ischemia in patients with severe coronary artery disease: focus on the efficacy and safety of gallopamil.
    Zehender M; Kosscheck U; Hohnloser S; Weiss C; Meinertz T; Just H
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S57-63. PubMed ID: 1284158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of gallopamil in coronary heart disease: a double blind cross-over comparison with nifedipine.
    Lazzeroni E; Morozzi L; Campana M; Botti G
    Eur Heart J; 1992 Apr; 13(4):526-30. PubMed ID: 1600993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of gallopamil on left ventricular systolic and diastolic function in patients with ischaemic heart disease.
    Di Mario C; Iavernaro A; Cucchini F
    Eur Heart J; 1991 Sep; 12(9):1006-11. PubMed ID: 1936000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of gallopamil and propranolol in patients with ischemic cardiopathy and moderate depression of ventricular function].
    Simarro E; Rodríguez MA; Bayón J; Lastra JA; Prieto P; Suárez G; García Porrero E; Fernández R; Garrido J; Velasco J
    Rev Esp Cardiol; 1995 Nov; 48(11):741-5. PubMed ID: 8532943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gallopamil and molsidomine in patients with coronary heart disease. A comparative study].
    Zebe H
    Fortschr Med; 1989 Feb; 107(5):134-8. PubMed ID: 2651251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Profile of the hemodynamic effect of gallopamil at rest and during exercise by angiocardio-scintigraphic studies: preliminary data].
    Tartagni F; Marchetti G; Maiello L; Dondi M; Franchi R; Magnani B
    Cardiologia; 1987 Nov; 32(11):1249-53. PubMed ID: 3447697
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of gallopamil on iodine-123-phenyl-pentadecanoic acid and thallium 201 uptake in patients with coronary heart disease].
    Tillmanns H; Zimmermann R; Kapp M; Rauch B; Neumann FJ; Schlumpp K; Bubeck B; Georgi P; Kübler W
    Z Kardiol; 1989; 78 Suppl 5():77-82. PubMed ID: 2698567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-ischemia effects of gallopamil and esmolol in an intra-individual comparison in patients with coronary heart disease].
    Mitrovic V; Oehm E; Minge C; Thürmann P; Schlepper M
    Z Kardiol; 1994 Jun; 83(6):431-8. PubMed ID: 7915067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Randomized comparison between gallopamil and diltiazem in angiography verified coronary heart disease].
    Zenker GD; Rödl S; Genger K
    Z Kardiol; 1989; 78 Suppl 5():94-7. PubMed ID: 2698570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
    Hopf R; Drews H; Kaltenbach M
    Z Kardiol; 1984 Sep; 73(9):578-85. PubMed ID: 6391005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exercise capacity of coronary heart disease patients in long-term follow-up with gallopamil in comparison with premedication with verapamil].
    Reiterer W
    Z Kardiol; 1989; 78 Suppl 5():63-8. PubMed ID: 2517157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of slow-release gallopamil in patients with stable exercise-inducible angina pectoris.
    Kottkamp H; Gülker H; Emmerich K; Koch HP; Minge C
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S88-94. PubMed ID: 1284163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
    Simonelli P; Papa A; Macciocchi B; Auriemma F; Vetrano A; Scaletta Romeo di Santillo M; Ceriello A
    Minerva Cardioangiol; 1993 May; 41(5):193-204. PubMed ID: 8355859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow-release gallopamil in patients with stable effort angina.
    Cherchi A; Lai C; Onnis E; Solinas R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S75-82. PubMed ID: 1284161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microperfusion in coronary artery disease under treatment with the calcium antagonist gallopamil.
    Eichstädt H; Danne O; Gutmann M; Langer M; Felix R; Schmutzler H
    Arzneimittelforschung; 1988 May; 38(5):700-3. PubMed ID: 3415712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of 75 mg retard gallopamil on stress-induced myocardial ischemia].
    Sinn R; Wolf R
    Z Kardiol; 1989; 78 Suppl 5():83-8. PubMed ID: 2698568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.